A Crossover Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention
Status:
Not yet recruiting
Trial end date:
2023-01-15
Target enrollment:
Participant gender:
Summary
A randomized, crossover study to evaluate the acceptability of an over-encapsulated dual
prevention pill (DPP capsule) containing pre-exposure prophylaxis (PrEP) and a combined oral
contraceptive (COC) pill versus two separate tablets (PrEP and COC) among adolescent girls
and young women (AGYW) at risk of HIV and unintended pregnancy in Harare, Zimbabwe